Taro Pharmaceutical Industries Ltd. (TARO) Thursday reported an increase in profit for the fourth quarter, driven mainly by a 13.8 percent growth in revenues.
The Haifa Bay, Israel-based company's attributable net income for the fourth quarter was $49.2 million or $1.10 per share, compared to $47.3 million or $1.06 per share in the comparable quarter last year.
Total revenues for the quarter rose 13.8% to $165.13 million from $145.14 million in the prior-year quarter.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.